Neoplas Med

Neoplas Med is a private German medical technology company developing and commercializing cold atmospheric plasma devices for wound care and dermatologic applications. Its lead and commercial product, kINPen MED, is described by the company as the first CE-marked atmospheric-pressure plasma jet approved as a Class IIa medical device for the treatment of chronic wounds and pathogen-induced skin disorders. The company emerged from plasma medicine research in Greifswald and focuses on contact-free, argon-based cold plasma treatment intended to accelerate wound healing and improve infection control. Neoplas Med appears to be a revenue-generating, venture-backed medtech company rather than a traditional drug developer, with commercial traction in Europe and ongoing work to expand reimbursement and international adoption.